view original post

Accolade Inc. (NASDAQ:ACCD) has seen 1.67 million shares traded in the last trading session. The company, currently valued at $1.30B, closed the last trade at $19.14 per share which meant it lost -$1.78 on the day or -8.51% during that session. The ACCD stock price is -213.11% off its 52-week high price of $59.93 and -9.25% below the 52-week low of $20.91. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.74 million shares traded. The 3-month trading volume is 679.61K shares.

The consensus among analysts is that Accolade Inc. (ACCD) is a Buy stock at the moment, with a recommendation rating of 1.30. 0 analysts rate the stock as a Sell, while 1 rate it as Overweight. 0 out of 12 have rated it as a Hold, with 11 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.74.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

Sporting -8.51% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Monday, 01/10/22 when the ACCD stock price touched $19.14 or saw a rise of 31.0%. Year-to-date, Accolade Inc. shares have moved -27.39%, while the 5-day performance has seen it change -29.58%. Over the past 30 days, the shares of Accolade Inc. (NASDAQ:ACCD) have changed -22.67%. Short interest in the company has seen 4.42 million shares shorted with days to cover at 5.41.

Wall Street analysts have a consensus price target for the stock at $46.45, which means that the shares’ value could jump 58.79% from current levels. The projected low price target is $31.00 while the price target rests at a high of $60.00. In that case, then, we find that the current price level is -213.48% off the targeted high while a plunge would see the stock gain -61.96% from current levels.

Accolade Inc. (ACCD) estimates and forecasts

Figures show that Accolade Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -64.08% over the past 6 months, with this year growth rate of -3.03%, compared to 11.10% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2022 fiscal year revenue. Growth estimates for the current quarter are -131.20% and -68.20% for the next quarter. Revenue growth from the last financial year stood is estimated to be 79.80%.

11 analysts offering their estimates for the company have set an average revenue estimate of $75.89 million for the current quarter. 11 have an estimated revenue figure of $97.71 million for the next quarter concluding in Feb 2022.

Earnings growth for 2022 is a modest -57.80% while over the next 5 years, the company’s earnings are expected to decrease by -0.90%.

ACCD Dividends

Accolade Inc. is expected to release its next earnings report on January 10 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Accolade Inc. (NASDAQ:ACCD)’s Major holders

Insiders own 3.67% of the company shares, while shares held by institutions stand at 73.50% with a share float percentage of 76.30%. Investors are also buoyed by the number of investors in a company, with Accolade Inc. having a total of 241 institutions that hold shares in the company. The top two institutional holders are ARK Investment Management, LLC with over 5.23 million shares worth more than $220.61 million. As of Sep 29, 2021, ARK Investment Management, LLC held 7.85% of shares outstanding.

The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 4.92 million shares as of Sep 29, 2021. The firm’s total holdings are worth over $207.35 million and represent 7.38% of shares outstanding.

>> 7 Top Picks for the Post-Pandemic Economy <<

Also the top two Mutual Funds that are holding company’s shares are ARK ETF Tr-ARK Genomic Revolution ETF and Vanguard Total Stock Market Index Fund. As of Oct 30, 2021, the former fund manager holds about 8.39% shares in the company for having 5.59 million shares of worth $222.5 million while later fund manager owns 1.5 million shares of worth $63.33 million as of Sep 29, 2021, which makes it owner of about 2.25% of company’s outstanding stock.